Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Vosyn launches AI Priorities, Impact & Investment Roadshow across Asia & the Middle East with live demos, investor briefings, and localized impact reports.
-
West Greenland Hub - Germanium, Gallium and Other Strategic Minerals Confirmed at West Greenland Hub
Reykjavík, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd.(“Amaroq” or the “Company”) West Greenland Hub Update **Re-assay confirms high grade mineralisation of zinc, lead and silver and newly...
-
Reykjavík, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sýnatökur staðfesta hátt hlutfall sinks, blýs og silfurs ásamt háu hlutfalli af skilgreindum US/EU þjóðaröryggis-málmum germanium, gallium og...
-
Three-year follow-up data from FIREFLY-1 demonstrates durable responses with evidence of clinical stability off treatment, with the potential for retreatment after progressionTreatment-free interval...
-
Calgary, Alberta, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Radiant Ridge Energy Ltd. (“RRE”), a leading energy infrastructure developer, today announced a strategic partnership with Nordcon Canada Inc....
-
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $51.5 million, or $1.87 per diluted share, for the third...
-
New York, USA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological...
-
VANCOUVER, CANADA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Novarc Technologies Inc. (“Novarc”), a full-stack AI robotics company pioneering automated welding solutions, today announced the launch of the...
-
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...
-
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...